Biopharmaceutical research and innovation by Oric Pharmaceuticals
Oric Pharmaceuticals moves enozertinib into Phase 3 trial: Will ORIC hold the MA-50?
Oric Pharmaceuticals highlighted new clinical data for its enozertinib candidate in first-line NSCLC patients with EGFR atypical mutations at ESMO2026 and disclosed plans for a Phase 3 trial. The ...
Oric Pharmaceuticals announces conference call and webcast review as stock rises 3.2%
Oric Pharmaceuticals set a date for a conference call and webcast to review clinical data from its ongoing Phase 1b trial of enozertinib in first-line NSCLC patients with EGFR atypical mutations. ...
Oric Pharmaceuticals joins 2026 Cantor Global Healthcare Conference fireside chat: Can ORIC break above $12.51?
Oric Pharmaceuticals executives are set to speak at the 2026 Cantor Global Healthcare Conference. The stock is down 1.3% on the day at $12.41.Oric Pharmaceuticals President and CEO Jacob Chacko ...
Oric Pharmaceuticals stock holds above key $10.58 level with limited downside seen
Oric Pharmaceuticals announced the initiation of its Himalayas-1 global Phase 3 study in mCRPC and a clinical trial collaboration and supply agreement with Bayer. At the same time, Oric ...
Oric Pharmaceuticals stock under pressure as daily decline signals short-term weakness
Oric Pharmaceuticals recognized the efforts of patients, families, caregivers, advocates, and researchers on World Lung Cancer Day.The company is advancing development of enozertinib, its ...
Oric Pharmaceuticals stock trades down to 10.69 as oricpharma promotes BTIG conference meeting
Oric Pharmaceuticals said its President and CEO, Jacob Chacko, and CFO, Dominic Piscitelli, will be available for investor one-on-one meetings at the BTIG Virtual Biotechnology Conference on July ...
Oric Pharmaceuticals stock extends rally with bullish signals after 22 percent weekly surge
Oric Pharmaceuticals wished its employees, collaborators, patients, and communities a safe and happy Independence Day.The company marked America's 250th anniversary in its Fourth of July message. ...
Oric Pharmaceuticals stock trades up as price holds above key supports despite mixed momentum
Oric Pharmaceuticals reports that its team recently volunteered with Ronald McDonald House and a local food bank.The company says the effort supported families and helped address food insecurity ...
Oric Pharmaceuticals stock drops 1.62% as Oric Pharmaceuticals marks Juneteenth with diversity message
Oric Pharmaceuticals marked Juneteenth by honoring the resilience, history, and contributions of Black Americans.The company stated that diversity is important in driving innovation and progress. ...
Oric Pharmaceuticals stock edges up 1.60% as company executives join Goldman Sachs healthcare event, oricpharma
Oric Pharmaceuticals will have its CFO Dom Piscitelli and CBO Matt Panuwat participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference. The event is scheduled for ...
Oric Pharmaceuticals stock falls 6.48% amid bearish momentum as Oric Pharmaceuticals honors cancer survivors
Oric Pharmaceuticals marked National Cancer Survivors Day by honoring cancer survivors. The company shared its ongoing focus on patient resilience.Oric Pharmaceuticals stated it is advancing ...
Oric Pharmaceuticals stock under sustained selling pressure, trades near new support zone
Oric Pharmaceuticals said President and CEO Jacob Chacko and CFO Dom Piscitelli will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026, at 11:40 a.m. ...
